IBDEI3B2 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,580,0)
 ;;=PROVIDER WEEKLY VISIT^1^67
 ;;^UTILITY(U,$J,358.4,581,0)
 ;;=ACCESS^5^68
 ;;^UTILITY(U,$J,358.4,582,0)
 ;;=DIALYSIS PROCEDURES^6^68
 ;;^UTILITY(U,$J,358.4,583,0)
 ;;=ESRD HOME SERVICES^7^68
 ;;^UTILITY(U,$J,358.4,584,0)
 ;;=HEMODIALYSIS OVERSIGHT^1^68
 ;;^UTILITY(U,$J,358.4,585,0)
 ;;=LAB^9^68
 ;;^UTILITY(U,$J,358.4,586,0)
 ;;=MEDICATIONS^10^68
 ;;^UTILITY(U,$J,358.4,587,0)
 ;;=MONITORING^11^68
 ;;^UTILITY(U,$J,358.4,588,0)
 ;;=OTHER^12^68
 ;;^UTILITY(U,$J,358.4,589,0)
 ;;=PATIENT EDUCATION/TEACHING^13^68
 ;;^UTILITY(U,$J,358.4,590,0)
 ;;=PATIENT MANAGEMENT^14^68
 ;;^UTILITY(U,$J,358.4,591,0)
 ;;=SUPPLIES^15^68
 ;;^UTILITY(U,$J,358.4,592,0)
 ;;=VACCINATIONS^16^68
 ;;^UTILITY(U,$J,358.4,593,0)
 ;;=DAILY DIALYSIS TXMT^2^68
 ;;^UTILITY(U,$J,358.4,594,0)
 ;;=INPATIENT DIALYSIS^8^68
 ;;^UTILITY(U,$J,358.4,595,0)
 ;;=PERITONEAL DIALYSIS^3^68
 ;;^UTILITY(U,$J,358.4,596,0)
 ;;=TEAM CONFERENCE^4^68
 ;;^UTILITY(U,$J,358.4,597,0)
 ;;=HEMODIALYSIS-ESRD^14^69
 ;;^UTILITY(U,$J,358.4,598,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^23^69
 ;;^UTILITY(U,$J,358.4,599,0)
 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^69
 ;;^UTILITY(U,$J,358.4,600,0)
 ;;=COMPLICATIONS/OTHER^4^69
 ;;^UTILITY(U,$J,358.4,601,0)
 ;;=CYSTIC KIDNEY DISEASE^5^69
 ;;^UTILITY(U,$J,358.4,602,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^69
 ;;^UTILITY(U,$J,358.4,603,0)
 ;;=FLUID/ELECTROLYTE DISORDER^8^69
 ;;^UTILITY(U,$J,358.4,604,0)
 ;;=GENERAL SYMPTOMS^9^69
 ;;^UTILITY(U,$J,358.4,605,0)
 ;;=GENITAL/URINARY^10^69
 ;;^UTILITY(U,$J,358.4,606,0)
 ;;=HEMATOLOGY^12^69
 ;;^UTILITY(U,$J,358.4,607,0)
 ;;=HYPERTENSION^15^69
 ;;^UTILITY(U,$J,358.4,608,0)
 ;;=INFECTIOUS DISEASE^16^69
 ;;^UTILITY(U,$J,358.4,609,0)
 ;;=NEPHRITIS GLUMERULONEPHRITIS^18^69
 ;;^UTILITY(U,$J,358.4,610,0)
 ;;=NEPHRITIS INTERSTITIAL^19^69
 ;;^UTILITY(U,$J,358.4,611,0)
 ;;=NEPHROTIC SYNDROME^21^69
 ;;^UTILITY(U,$J,358.4,612,0)
 ;;=OBSTRUCTIVE UROPATHY^22^69
 ;;^UTILITY(U,$J,358.4,613,0)
 ;;=TRANSPLANT^26^69
 ;;^UTILITY(U,$J,358.4,614,0)
 ;;=CKD/KIDNEY DISEASE^3^69
 ;;^UTILITY(U,$J,358.4,615,0)
 ;;=HEMODIALYSIS-AKI^13^69
 ;;^UTILITY(U,$J,358.4,616,0)
 ;;=ACUTE KIDNEY INJURY^1^69
 ;;^UTILITY(U,$J,358.4,617,0)
 ;;=GLOMERULAR DISEASE^11^69
 ;;^UTILITY(U,$J,358.4,618,0)
 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^69
 ;;^UTILITY(U,$J,358.4,619,0)
 ;;=NEPHROLITHASIS^20^69
 ;;^UTILITY(U,$J,358.4,620,0)
 ;;=POISONING & INTOXICATIONS^24^69
 ;;^UTILITY(U,$J,358.4,621,0)
 ;;=DIALYSIS^7^69
 ;;^UTILITY(U,$J,358.4,622,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^25^69
 ;;^UTILITY(U,$J,358.4,623,0)
 ;;=IMMUNIZATION^10^70
 ;;^UTILITY(U,$J,358.4,624,0)
 ;;=MEDICATION^12^70
 ;;^UTILITY(U,$J,358.4,625,0)
 ;;=ORTHO/JOINTS^6^70
 ;;^UTILITY(U,$J,358.4,626,0)
 ;;=RESPIRATORY SYSTEM^13^70
 ;;^UTILITY(U,$J,358.4,627,0)
 ;;=CRITICAL CARE/PULM/SEDATION^3^70
 ;;^UTILITY(U,$J,358.4,628,0)
 ;;=GI/GYN^7^70
 ;;^UTILITY(U,$J,358.4,629,0)
 ;;=NEURO/EYE/ENT^8^70
 ;;^UTILITY(U,$J,358.4,630,0)
 ;;=LACERATIONS^5^70
 ;;^UTILITY(U,$J,358.4,631,0)
 ;;=SKIN WOUNDS/BURNS^4^70
 ;;^UTILITY(U,$J,358.4,632,0)
 ;;=PSYCHIATRY^9^70
 ;;^UTILITY(U,$J,358.4,633,0)
 ;;=COMMON PROCEDURES^1^70
 ;;^UTILITY(U,$J,358.4,634,0)
 ;;=INFUSION/INJECTION ADMIN^11^70
 ;;^UTILITY(U,$J,358.4,635,0)
 ;;=ADDITIONAL VISIT CODES^2^70
 ;;^UTILITY(U,$J,358.4,636,0)
 ;;=EMERGENCY DEPT VISIT^1^71
 ;;^UTILITY(U,$J,358.4,637,0)
 ;;=TRIAGE ONLY (NO MD SEEN)^4^71
 ;;^UTILITY(U,$J,358.4,638,0)
 ;;=ED OBS 1ST DAY-INIT^3^71
